pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet [Wal-Act]
- RxCUI
- 1099774
- RxNorm name
- pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet [Wal-Act]
- Display name
- WAL-ACT (Oral Pill)
- Full name
- pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet [Wal-Act]
- Term type
- SBD
- Status
- Active
- Strength
- 60-2.5 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-07-27 06:54:30
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 052011
- Active start
- 052011
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
Derived Ingredient Concepts#
RxNav Current And Historical NDCs#
NDC11, Source, Active table| NDC11 | Source | Active |
|---|
| 00363017822 | rxnav_ndcs | yes |
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | R06AX | Other antihistamines for systemic use | ATC1-4 | | triprolidine |
| ATC | R01BA | Sympathomimetics | ATC1-4 | | pseudoephedrine |
| FDASPL | N0000175552 | alpha-Adrenergic Agonist | EPC | has_epc | pseudoephedrine |
| MEDRT | D054199 | Pseudoephedrine | CHEM | has_ingredient | pseudoephedrine |
| MEDRT | D054199 | Pseudoephedrine | CHEM | has_ingredient | pseudoephedrine hydrochloride |
| MEDRT | D014311 | Triprolidine | CHEM | has_ingredient | triprolidine hydrochloride |
| MEDRT | D014311 | Triprolidine | CHEM | has_ingredient | triprolidine |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | pseudoephedrine |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | pseudoephedrine hydrochloride |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | pseudoephedrine hydrochloride |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | pseudoephedrine |
| MEDRT | D003233 | Conjunctivitis, Allergic | DISEASE | may_treat | triprolidine hydrochloride |
| MEDRT | D003233 | Conjunctivitis, Allergic | DISEASE | may_treat | triprolidine |
| MEDRT | D003327 | Coronary Disease | DISEASE | ci_with | triprolidine hydrochloride |
| MEDRT | D003327 | Coronary Disease | DISEASE | ci_with | triprolidine |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | triprolidine hydrochloride |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | triprolidine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | pseudoephedrine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | pseudoephedrine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | triprolidine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | triprolidine hydrochloride |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | triprolidine hydrochloride |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | triprolidine |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | pseudoephedrine |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | pseudoephedrine hydrochloride |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | pseudoephedrine |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | pseudoephedrine hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | pseudoephedrine hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | pseudoephedrine |
| MEDRT | N0000000245 | Adrenergic beta-Agonists | MOA | has_moa | pseudoephedrine |
| MEDRT | N0000000245 | Adrenergic beta-Agonists | MOA | has_moa | pseudoephedrine hydrochloride |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | triprolidine hydrochloride |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | triprolidine |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | triprolidine |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | pseudoephedrine |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | triprolidine hydrochloride |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | pseudoephedrine hydrochloride |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | pseudoephedrine hydrochloride |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | pseudoephedrine |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | triprolidine |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | triprolidine hydrochloride |
| MEDRT | N0000009908 | Vasoconstriction | PE | has_pe | pseudoephedrine |
| MEDRT | N0000009908 | Vasoconstriction | PE | has_pe | pseudoephedrine hydrochloride |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 60 MG / 2.5 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| ATTRIBUTES | TTY | SBD |
| CODES | MMSL_CODE | BD3888 |
| CODES | RxCUI | 1099774 |
| NAMES | Prescribable Synonym | Wal-Act Cold & Allergy 2.5 MG / 60 MG Oral Tablet |
| NAMES | RXNAV_STR | Wal-Act (pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG) Oral Tablet |
| NAMES | RxNorm Name | pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet [Wal-Act] |
| NAMES | RxNorm Synonym | Wal-Act (pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG) Oral Tablet |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Multum MediSource Lexicon |